Clik here to view.
Stem cell therapeutic products on the market
Updated on Mar. 6, 2012 Last year I wrote about some regenerative medicine and cell therapy products on the market. You can find updated list here. But what is the value of stem cell products among...
View ArticleClik here to view.
Trends in regenerative medicine industry – from 2007 to 2011
New report about a progress in regenerative medicine industry was just published online in Tissue Engineering Part B. This is a detailed update to 2008 Lysaght’s report. The report contains a lot of...
View ArticleAlliance for Regenerative Medicine’s 2012 Report
Alliance for Regenerative Medicine has published 2012 Industry Report and made it available for the public. It’s interesting and informative report. I’d encourage you to read it. A quick snapshot and...
View ArticleClik here to view.
Success of cell therapy producs after approval
Right now, each approval of cell therapy product on the market we’re cheering by “Wow!”. Maybe 5 years from now, we would say “so what?”. The recent example – Prochymal approval by Health Canada for...
View ArticleClik here to view.
Stem cell therapy industry is booming in Korea
Approval of stem cell therapeutic products is progressing slowly around the world. There are many hurdles in manufacturing, business development and regulation of these highly complex biological...
View ArticleRegenMed and stem cell gadgets review – 2012 part II
Last year we introduced the term “regenmed gadget“. Since that we reviewed a variety of gadgets and new smart technologies. This is the 5th issue of our “gadgets review”. 1. The first prototype of...
View ArticleStem cells for Pharma’s R&D
One of the biggest potential markets for stem cells is research and development (R&D) in Pharma industry. While everybody is exciting about therapeutic potential of stem cells, R&D business...
View ArticleNotable market approvals in 2012
This year is very interesting for RegenMed and cell therapy industry. There were a number of notable market approvals, including stem cell, gene and tissue engineered products. In order to keep track...
View ArticleClik here to view.
Regenerative medicine funding trends in US
Funding is one of the main hurdles for regenerative medicine/ cell therapy translation into the clinic. It was suggested in few conferences that government agencies should recognize the importance of...
View ArticleRegenerative medicine and cell therapy industry in 2012
As usual, at the end of the year, I overview the most interesting and important events in cell therapy and Regen industry. The list of top 10 events reflects solely my opinion. 1. Debate on regulation...
View ArticleClik here to view.
Autologous versus allogeneic business model
There are two major business models in cell therapy and regenerative medicine industry – autologous and allogeneic. Each model has pros and cons. I’d briefly summarize features of each model as the...
View ArticleRegenerative medicine industry 2013 report
The Alliance for Regenerative Medicine (ARM) just issued an Annual 2013 Report. It’s absolutely worth a look/ download and read! ARM is US-based advocacy organization, aimed to promote clinical...
View ArticlePublic versus private cell therapy and stem cell companies
Cell therapy and RegenMed industry has a great variety of public and private companies. Currently, the overall value of public companies is much lower then private. If we look at cell therapy field,...
View ArticleTrends in clinical use of point-of-care cell processing devices
One of my favorite workshops at the recent ISCT North America regional meeting was a point-of-care cell processing devices. The topic is very hot and capturing a lot of attention in cell therapy...
View ArticleBig Pharma acquires stem cell, RegenMed and cell therapy assets
While ago, I’ve written about relationships between Pharma/ Biotech and cell therapy industry. Few years back, Pharma still was curious and “sniffing air” around, but what about now? This year, I’ve...
View Article10 new companies to watch
I’ve decided to do an experiment and overview some new companies that I like. If you like the idea, I can do it 1-2 times per year. You can suggest new cool companies to me. In order to pick companies...
View ArticleRegenMed, stem cell and cell therapy industry in 2013
At the end of the year, I overview the most interesting and important events in stem cell/ RegenMed/ cell therapy industry. This year I’d like to focus on trends, rather than separate events. Here is...
View ArticleClik here to view.
Trends in cell therapy industry clinical trials
As a part of a CellTrials project, I’m tracking all cell therapy clinical trials, registered in international databases. You can read more about the tracking project here and follow annual updates....
View Article10 new companies to watch – part 2
5 months ago I’ve picked and brought to your attention a list of new interesting companies. In the last few months, I’ve learned more companies, and today, I’m sharing the new list of 10 with you. As...
View ArticleClik here to view.
The role of translational centers in regenerative medicine industry
Cell-based products are very complex and represent unique class of therapeutic biologics. Unlike Biotech and Pharma, the vast majority of cell-/ regenerative medicine (RM) products are created in...
View Article
